Pan-Biome Pharmaceuticals Inc CEO Gordon Eberwein Chief Scientific Officer Poul Sorensen and Chief of Clinical Development Anne-Chloe Dhez joined Proactive’s Steve Darling to talk about the company and where they are at and where they began.
Eberwein tells Proactive some of the goals the company has over the next 6-12 months. Sorensen talks about the main focus of the company while Dhez explains the compounds and what they are designed to do.